Analysis

  • Virus-Like Particles: Vaccines of Tomorrow?

    Virus-like particles represent one of the most exciting new technologies to rapidly produce vaccines. Elisabeth Fischer speaks to industry experts to find out about this cheaper and quicker way to...

  • Contract Chemistry: The Custom Synthesis Market

    When pharmaceutical companies need compounds for drug development, custom synthesis providers satisfy demand. Chris Lo talks to Onyx Scientific CEO Tony Flinn about the challenges of synthesising molecules to a...

  • Preventing the Fallout: Anti-Radiation Drugs

    The disaster at the Fukushima nuclear plant in Japan has triggered demand for a powerful anti-radiation drug. Elisabeth Fischer finds out what options are currently out there and asks just...

  • HIV: Hope on the Horizon?

    Treatment for HIV / Aids is more sophisticated than ever, but how much closer are we to finding a cure? Chris Lo investigates the colossal challenges for organisations trying to...

Close
Close
Close

Go Top